Inside SMP proteomics: Six years German Human Brain Proteome Project (HBPP) – A summary

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proteomics

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pmic.200700980PMID 18283670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Creatine improves health and survival of mice.

  2008cited by this paper
• Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

  2008cited by this paper
• A three‐symbol code for organized proteomes based on cyclical imaging of protein locations

  2007cited by this paper
• ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome

  2007cited by this paper
• A new fast method for nanoLC-MALDI-TOF/TOF-MS analysis using monolithic columns for peptide preconcentration and separation in proteomic studies.

  2007cited by this paper
• High MS‐compatibility of silver nitrate‐stained protein spots from 2‐DE gels using ZipPlates and AnchorChips for successful protein identification

  2007cited by this paper
• High Performance Proteomics: 7th HUPO Brain Proteome Project Workshop March 7–9, 2007 Wellcome Trust Conference Centre, Hinxton, UK

  2007cited by this paper
• Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase.

  2007cited by this paper
• Multidimensional chromatography: a powerful tool for the analysis of membrane proteins in mouse brain.

  2007cited by this paper
• Comparative thermodynamic analysis of cyclic nucleotide binding to protein kinase A

  2007cited by this paper
• Proteomics for everyday use: Activities of the HUPO Brain Proteome Project during the 5th HUPO World Congress

  2007cited by this paper
• Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

  2007cited by this paper
• Subacute proteome changes following traumatic injury of the developing brain: Implications for a dysregulation of neuronal migration and neurite arborization

  2007cited by this paper
• Plasma protein binding properties to immobilized heparin and heparin-albumin conjugate.

  2007cited by this paper
• Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

  2007cited by this paper
• Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice.

  2007cited by this paper
• Differential binding studies applying functional protein microarrays and surface plasmon resonance

  2006cited by this paper
• CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

  2006cited by this paper
• The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.

  2006cited by this paper
• Current Developments for the In Vitro Characterization of Protein Interactions

  2006cited by this paper
• Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity

  2006cited by this paper
• Analysis of posttranslational modifications exemplified using protein kinase A.

  2006cited by this paper
• 4th HUPO Brain Proteome Project Workshop in Munich, Germany

  2006cited by this paper
• Biomolecular interaction analysis in functional proteomics

  2006cited by this paper
• High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase A-anchoring disruptor peptides.

  2006cited by this paper
• International quality control survey of neurochemical dementia diagnostics.

  2006cited by this paper
• Evolution of primate gene expression

  2006cited by this paper
• The HUPO Brain Proteome Project – No need to hurry?

  2006cited by this paper
• Functionality of Intergenic Transcription: An Evolutionary Comparison

  2006cited by this paper
• Evaluation of 2‐DE protein patterns from pre‐ and postnatal stages of the mouse brain

  2006cited by this paper
• Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides.

  2006cited by this paper
• Quintessence from proteomics networks – the HUPO Brain Proteome Project Pilot Studies

  2006cited by this paper
• Estimation of the mtDNA mutation rate in aging mice by proteome analysis and mathematical modeling.

  2006cited by this paper
• Translational control of collagen prolyl 4-hydroxylase-alpha(I) gene expression under hypoxia.

  2006cited by this paper
• Reverse genetics for proteomics: From proteomic discovery to scientific content

  2006cited by this paper
• PGE1 stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases

  2006cited by this paper
• Positive selection on gene expression in the human brain.

  2006cited by this paper
• Characterization of A-kinase-anchoring disruptors using a solution-based assay.

  2006cited by this paper
• Quantification of cAMP antagonist action in vitro and in living cells.

  2006cited by this paper
• HUPO Brain Proteome Project: Summary of the pilot phase and introduction of a comprehensive data reprocessing strategy

  2006cited by this paper
• Proteomics in neurodegeneration – disease driven approaches

  2006cited by this paper
• Decreased circulating CD34+ stem cells in early Alzheimer's disease: evidence for a deficient hematopoietic brain support?

  2006cited by this paper
• Pilot study of the Human Proteome Organisation Brain Proteome Project: Applying different 2‐DE techniques to monitor proteomic changes during murine brain development

  2006cited by this paper
• Analysis of the HUPO Brain Proteome reference samples using 2‐D DIGE and 2‐D LC‐MS/MS

  2006cited by this paper
• Study of posttranslational modifications in lenticular alphaA-Crystallin of mice using proteomic analysis techniques.

  2006cited by this paper
• CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodies

  2006cited by this paper
• MMI1 (YKL056c, TMA19), the yeast orthologue of the translationally controlled tumor protein (TCTP) has apoptotic functions and interacts with both microtubules and mitochondria.

  2006cited by this paper
• Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).

  2006cited by this paper
• Differential Analysis of Saccharomyces cerevisiae Mitochondria by Free Flow Electrophoresis*S

  2006cited by this paper
• Automated reprocessing pipeline for searching heterogeneous mass spectrometric data of the HUPO Brain Proteome Project pilot phase

  2006cited by this paper
• Application of Bioluminescence Resonance Energy Transfer (BRET) for Biomolecular Interaction Studies

  2006cited by this paper
• Acute and long-term proteome changes induced by oxidative stress in the developing brain

  2006cited by this paper
• Analyzing proteome topology and function by automated multidimensional fluorescence microscopy

  2006cited by this paper
• Proteins are specifically altered in disease – really?

  2006cited by this paper
• Preface – Special Issue: Proteomics in neurodegeneration – from samples to target proteins and biomarkers

  2006cited by this paper
• Cytomics in characterizing Toponomes: Towards the biological code of the cell

  2006cited by this paper
• The power of cooperative investigation: Summary and comparison of the HUPO Brain Proteome Project pilot study results

  2006cited by this paper
• Selenium‐binding protein 2, the major hepatic target for acetaminophen, shows sex differences in protein abundance

  2006cited by this paper
• Exploring molecular networks directly in the cell

  2006cited by this paper
• 2‐D differential membrane proteome analysis of scarce protein samples

  2006cited by this paper
• Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking.

  2006cited by this paper
• Administrative Optimization of Proteomics Networks for Drug Development

  2006cited by this paper
• Proteomics in Drug Research: HAMACHER: PROTEOMICS IN DRUG RESEARCH O-BK

  2006cited by this paper
• The German Competence Net Dementias: Standard operating procedures for the neurochemical dementia diagnostics

  2006cited by this paper
• Parallel Patterns of Evolution in the Genomes and Transcriptomes of Humans and Chimpanzees

  2005cited by this paper
• Tryptic transpeptidation products observed in proteome analysis by liquid chromatography‐tandem mass spectrometry

  2005cited by this paper
• Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells.

  2005cited by this paper
• Identification of coexpressed gene clusters in a comparative analysis of transcriptome and proteome in mouse tissues.

  2005cited by this paper
• “Subcellular Proteomics” of Neuromelanin Granules Isolated from the Human Brain*

  2005cited by this paper
• Application of proteomics and protein analysis for biomarker and target finding for immunotherapy.

  2005cited by this paper
• Direct optical detection of protein-ligand interactions.

  2005cited by this paper
• HUPO Brain Proteome Project Pilot Studies: Bioinformatics at Work

  2005cited by this paper
• Systematic analysis of gene expression in human brains before and after death

  2005cited by this paper
• HUPO BPP Workshop on Mouse Models for Neurodegeneration – Choosing the right models

  2005cited by this paper
• How proteomics reveals potential biomarkers in brain diseases

  2005cited by this paper
• Rearrangements in a hydrophobic core region mediate cAMP action in the regulatory subunit of PKA

  2005cited by this paper
• Great mood in proteomics: Beijing and the HUPO Human Brain Proteome Project

  2005cited by this paper
• HUPO Brain Proteome Project: aims and needs in proteomics

  2005cited by this paper
• EMPReSS: standardized phenotype screens for functional annotation of the mouse genome

  2005cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• A two‐dimensional electrophoretic map of human mitochondrial proteins from immortalized lymphoblastoid cell lines: A prerequisite to study mitochondrial disorders in patients

  2005cited by this paper
• 5th HUPO BPP Bioinformatics Meeting at the European Bioinformatics Institute in Hinxton, UK – Setting the Analysis Frame

  2005cited by this paper
• [Home nursing of demented patients as an economic factor in public health].

  2004cited by this paper
• High reproducibility of large‐gel two‐dimensional electrophoresis

  2004cited by this paper
• A peptide preconcentration approach for nano‐high‐performance liquid chromatography to diminish memory effects

  2004cited by this paper
• Assessment of a systematic expression profiling approach in ENU-induced mouse mutant lines

  2004cited by this paper
• Influence of Huntington's disease on the human and mouse proteome.

  2004cited by this paper
• Proteomics--application to the brain.

  2004cited by this paper
• Determination of kinetic data using surface plasmon resonance biosensors.

  2004cited by this paper
• Dietary factors and Alzheimer's disease.

  2004cited by this paper
• A Nonredundant Human Protein Chip for Antibody Screening and Serum Profiling*

  2003cited by this paper
• Genetic analysis of the mouse brain proteome

  2002cited by this paper
• Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

  1989cited by this paper

• Global Approaches to the Analysis of Cocaine-Induced Gene Expression

  2017cites this paper
• The chromosome-centric human proteome project: a call to action.

  2013cites this paper
• BRAIN SENESCENCE-OMICS

  2013cites this paper
• Reconstructing and analysing protein-protein interaction networks of synaptic molecular machines

  2012cites this paper
• Systems biology of Alzheimer's disease: how diverse molecular changes result in memory impairment in AD.

  2011cites this paper
• Neuroproteomics: understanding the molecular organization and complexity of the brain

  2009cites this paper